Mutual fund · AMFI 152349
WhiteOak Capital Pharma and Healthcare Fund
NAV ₹18.30 · 18 Nov 2026
WhiteOak Capital Pharma and Healthcare Fund is a sectoral fund mutual fund run by . Its NAV was ₹18.30 on 18 Nov 2026, up 25.7% over one year. The direct plan's total expense ratio was 1.04% in the latest AMFI data. The top 10 holdings made up 44.6% of the portfolio in October 2026.
Returns from NAV
One year and shorter are absolute; three and five years are annualised. Based on NAV, so dividend payouts are not added back. Past performance does not guarantee future results.
Risk · last 2.8 years
How bumpy the ride has been
Worked out from weekly NAVs. The largest fall ran from 02 Jan 2025 to 28 Feb 2025. Sharpe and Sortino use a fixed 6.5% a year risk-free rate for comparison. Past figures are not a guide to future returns.
What the fund charges
From AMFI's expense ratio data, updated 19 Nov 2026. The regular plan charges more; see the fund's factsheet.
Portfolio · October 2026
Top holdings (63 in total)
| Company | % of fund | vs last month |
|---|---|---|
| Divi's Laboratories Limited | new | |
| Sun Pharmaceutical Industries Limited | new | |
| Torrent Pharmaceuticals Limited | new | |
| Laurus Labs Limited | new | |
| Apollo Hospitals Enterprise Limited | new | |
| Zydus Lifesciences Limited | new | |
| Sai Life Sciences Limited | new | |
| IPCA Laboratories Limited | new | |
| Mankind Pharma Limited | new | |
| Corona Remedies Limited | new | |
| Aurobindo Pharma Limited | new | |
| Acutaas Chemicals Limited | new | |
| Cipla Limited | new | |
| Ajanta Pharma Limited | new | |
| Krishna Institute Of Medical Sciences Limited | new |
The top 10 make up 44.6% of the fund. Source: the fund house's monthly portfolio disclosure.
By sector
Where the money is
Pharmaceuticals & Biotechnology63.1%
Healthcare Services20.7%
Sovereign4.1%
Chemicals & Petrochemicals3.5%
Consumer Durables1.7%
Healthcare Equipment & Supplies1.5%
Learn more
Mutual fund guides
Your mutual funds
Review your own mutual fund portfolio
Upload or fetch your holdings and see each fund's returns, cost and overlap against benchmarks, as facts. Review my mutual funds
Questions
About WhiteOak Capital Pharma and Healthcare Fund
What is the NAV of WhiteOak Capital Pharma and Healthcare Fund?
The net asset value was Rs 18.30 on 18 November 2026.
What is the expense ratio of WhiteOak Capital Pharma and Healthcare Fund?
The direct plan's total expense ratio was 1.04% in the latest AMFI data, about Rs 10,400 a year on Rs 10 lakh invested.
What is the one-year return of WhiteOak Capital Pharma and Healthcare Fund?
The NAV changed by 25.7% over the last year; past returns do not indicate future returns.
Data source: AMFI (Association of Mutual Funds in India) for NAVs and expense ratios; portfolio holdings from the fund house's monthly disclosures.
Data: AMFI NAVs and expense ratios and the fund house's monthly portfolio disclosures. This page states facts and is not a recommendation to buy or sell. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance does not guarantee future results.